Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0OW5Y
|
||||
| Former ID |
DIB004439
|
||||
| Drug Name |
NW-1772
|
||||
| Synonyms |
Monoamine oxidase B inhibitors (neurodegenerative disease), Newron; MAO-B inhibitors (neurodegenerative disease), Newron
|
||||
| Indication | Neurodegenerative disease [ICD9: 330-337; ICD10:G30-G32] | Investigative | [543639] | ||
| Company |
Newron Pharmaceuticals SpA
|
||||
| Canonical SMILES |
S(=O)(=O)(O)C.c12oc(=O)cc(c1ccc(c2)OCc1cc(Cl)ccc1)CNC
|
||||
| Target and Pathway | |||||
| Target(s) | Amine oxidase [flavin-containing] B | Target Info | Inhibitor | [543639] | |
| KEGG Pathway | Glycine, serine and threonine metabolism | ||||
| Arginine and proline metabolism | |||||
| Histidine metabolism | |||||
| Tyrosine metabolism | |||||
| Phenylalanine metabolism | |||||
| Tryptophan metabolism | |||||
| Drug metabolism - cytochrome P450 | |||||
| Metabolic pathways | |||||
| Serotonergic synapse | |||||
| Dopaminergic synapse | |||||
| Cocaine addiction | |||||
| Amphetamine addiction | |||||
| Alcoholism | |||||
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.